 "Mitsui aims to accelerate business in healthcare and nutrition segments")
TOKYO (Reuters) - Japanese trading house Mitsui & Co Ltd aims to accelerate its business expansion in healthcare and nutrition, using Malaysian hospital group IHH Healthcare Bhd and other assets, its chief executive officer (CEO) said on Friday.
Speaking at an analyst meeting following its earnings announcement last week, Mitsui CEO Kenichi Hori said: "What we are targeting in healthcare and nutrition areas in a long term is quite large."
However, he did not discuss a Bloomberg report on Thursday that Mitsui is exploring a deal to take IHH Healthcare private.
Mitsui is the biggest shareholder in IHH Healthcare, owning 32.9% stake.
(Reporting by Yuka Obayashi; Editing by Christian Schmollinger)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app